← All organizations

Climb Bio, Inc.

For profitWebsite ↗

Also known as: Climb Bio, Inc. | Eliem Therapeutics (UK) Ltd.

Highest phase reached

Phase 2

First clinical trial

Nov 9, 2020

Last known activity

Dec 31, 2025

Timeline

2010s

  1. Jan 1, 2018

    Climb Bio, Inc.— Founded

2020s

  1. Nov 1, 2024

    Tenet Medicines— Acquired

Drugs by trial phase (3 distinct, 8 trials)

Phase 2 (1 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (9)

Details

Founded
Wellesley, MA, US Jan 1, 2018
Last known activity
Dec 31, 2025